Serum Interleukin-1, Interleukin-2, Interleukin-6, and Prolactin Levels Are Not Associated with the Severity of Disease in Patients with the Irritable Bowel Syndrome, with or Without Concomitant Fibromyalgia

REFERENCES

• Thompson W G, Dotevall G, Drossman D A, Heaton K W, Kruis W. Irritable bowel syndrome: guidelines for the diagnosis. Gastroenterol Int 1989; 2: 92–95
   Google Scholar
• Thompson W G, Creed F, Drossman D A, Heaton K W, Mazzacca G. Functional bowel disorders and chronic functional abdominal pain. Gastroenterol Int 1992; 5: 75–91
   Google Scholar
• Taub E, Cuevas J L, Cook E W, Cromwell M, Whitehead W E. Irritable bowel syndrome defined by factor analysis: gender and race comparisons. Dig Dis Sci 1995; 40: 1761–1769
   Web of Science ®Google Scholar
• Kay L, Jorgensen T, Jensen K H. The Epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors. J Int Med 1994; 236: 23–30
   PubMed Web of Science ®Google Scholar
• Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ 1992; 304: 87–90
   PubMed Web of Science ®Google Scholar
• Heaton K W, O'Donnell L JD, Braddon F EM, Mountford R A, Hughes A O, Cripps P J. Symptoms of the irritable bowel syndrome in a British urban community: consulters and nonconsulters. Gastroenterology 1992; 102: 1962–1967
   PubMed Web of Science ®Google Scholar
• Drossman D A, et al. U.S. householder survey of functional GI disorders: prevalence, sociodemography and health impact. Dig Dis Sci 1993; 38(1569)
   PubMed Web of Science ®Google Scholar
• Talley N J, Zinsmeister A R, Van Dyke C, Melton L J, III. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991; 101: 927–934
   PubMed Web of Science ®Google Scholar
• Pace F, Manzionna G, Bollani S, Sarzi-Puttini P, Bianchi Porro G. Visceral sensitivity in patients with fibromyalgia and in normal patients. Gastroenterology 1997; 112(#4)A802
   Web of Science ®Google Scholar
• Hudson J I, Goldenberg D L, Pope H GJ, Keck P EJ, Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 1992; 92: 363–367
   PubMed Web of Science ®Google Scholar
• Triadafilopoulos G, Simms R W, Goldenberg D L. Bowel dysfunction in fibromyalgia syndrome. Dig Dis Sci 1991; 36: 59–64
   PubMed Web of Science ®Google Scholar
• Romano T J. Coexistence of irritable bowel syndrome and fibromyalgia. W V Med J 1988; 84: 16–18
   PubMedGoogle Scholar
• Sivri A, Cindas A, Dincer F, Sivri B. Bowel dysfunction and irritable bowel syndrome in fibromyalgia patients. Clin Rheumatol 1996; 15: 283–286
   PubMed Web of Science ®Google Scholar
• Yunus M B, Masi A T, Calabro J J, Miller K A, Feigenbaum S L. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arth Rheum 1981; 11: 151–171
   PubMed Web of Science ®Google Scholar
• Veale D, Kavanagh G, Fielding J F, Fitzgerald O. Primary fibromyalgia and the irritable bowel syndrome: different expressions of a common pathogenetic process. Br J Rheumatol 1991; 30: 220–222
   PubMedGoogle Scholar
• Campbell S M, Clark S, Tindall E A, Forehand M E, Bennett R M. Clinical characteristics of fibrositis. 1. A “blinded” controlled study of symptoms and tender points. Arthritis Rheum 1983; 26: 817–824
   PubMed Web of Science ®Google Scholar
• Yunus M B. Fibromyalgia syndrome: clinical features and spectrum. J Musculoskeletal Pain 1994; 2(3)5–21
   Google Scholar
• Gruber A J, Hudson J I, Pope H GJ. The management of treatment-resistant depression in disorders on the interface of psychiatry and medicine. Psychiatr Clin N Amer 1996; 19: 351–369
   PubMed Web of Science ®Google Scholar
• Watkins A. Mind-body pathways, Mind-Body Medicine., A Watkins. Churchill Livingstone, New York 1997; 1–25
   Google Scholar
• Ferraccioli G, Cavalieri F, Salaffi F, et al. Neuroendocrinologic findings in primary fibromyalgia (soft tissue chronic pain syndrome) and in other chronic rheumatic conditions (rheumatoid arthritis, low back pain). J Rheumatol 1990; 17: 869–873
   PubMed Web of Science ®Google Scholar
• Buskila D, Fefer P, Harman-Boehm I, Press J, Neumann L, Lunenfeld E, Gedalia A, Potashnik G, Sukenik S. Assessment of nonarticular tenderness and prevalence of fibromyalgia in hyperprolactinemic women. J Rheumatol 1993; 20: 2112–2115
   PubMed Web of Science ®Google Scholar
• Jara L J, Lavalle C, Fraga A, Gomez-Sanchez C, Silveira L H, Martinez-Osuna P, Germain B F, Espinoza L R. Prolactin, immunoregulation, and autoimmune diseases. Semin Arth Rheum 1991; 20: 273–284
   PubMed Web of Science ®Google Scholar
• McMurray R W, Hoffman R W, Walker S E. In vivo prolactin manipulation alters in vitro IL-2, IL-4 and IFN-gamma mRNA levels in female B/W mice. Clin Res 1991; 39: 734A
   Google Scholar
• Derogatis L R. SCL-90-R. Towson, MD: Clinical Psychometric Research, Maryland 1983
   Google Scholar
• Derogatis L R. SCL-90-R. A bibliography of research reports: 1975–1990. Towson, MD: Clinical Psychometric Research, Maryland 1990
   Google Scholar
• Spielberger C D, Gorsuch R L, Lushene R I. Manual for State-Trait Anxiety Inventory. Consulting Psychologists Press, Palo Alto, CA 1970
   Google Scholar
• Sperber A D, DeVellis R F, Boehlecke B. Cross-cultural translation: methodology and validation. J Cross-Cult Psychol 1994; 25: 501–504
   Web of Science ®Google Scholar
• Drossman S A, Li Z, Toner B B, Diamant N E, Creed F H, Thompson D, Read N W, Babbs C, Barreiro M, Bank L, Whitehead W E, Schuster M M, Guthrie E A. Functional Bowel Disorders. a multicenter comparison of health status and development of illness severity index. Dig Dis Sci 1995; 40: 986–995
   PubMed Web of Science ®Google Scholar
• Wolfe F, Smythe H A, Yunus M B, Bennett R M, Bombardier C, Goldenberg D L, Tugwell P, Campbell S M, Abeles M, Clark P, Fam A G, Farber S J, Fiechtner J J, Franklin C M, Gatter R A, Hamaty D, Lessard J, Lichtbroun A S, Masi A T, McCain G A, Reynolds W J, Romano T J, Russell I J, Sheon R P. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum, 33: 160–172, 1990
   PubMed Web of Science ®Google Scholar
• Melhem M F, Meisler A I, Saito R, Finley G G, Hockman H R, Koski R A. Cytokines in inflammatory malignant fibrous histiocytoma presenting with leukemoid reaction. Blood 1993; 82: 2038–2044
   PubMed Web of Science ®Google Scholar
• Ihn H, Sato S, Fujimoto M, Kikuchi K, Takehara K. Demonstration of interleukin-2, interleukin-4, and interleukin-6 in sera from patients with localized scleroderma. Arch Dermatol Res 1995; 287: 193–197
   PubMed Web of Science ®Google Scholar
• Baines M G, Rafferty B, Patel U, Ferguson K, Jeffcoate S L, Thorpe R. The production and characterization of nonclonal antibodies against human prolactin and the development of a two-site immunoradiometric assay. J Immunoassay 1989; 10: 75–91
   PubMed Web of Science ®Google Scholar
• Mukhergee P, Mastro A M, Hymer W C. Prolactin induction of interleukin-2 receptors on rat splenic lymphocytes. Endocrinol 1990; 126: 88–94
   PubMed Web of Science ®Google Scholar
• Spangelo B L, Hall N RS, Ross P C, Goldstein A L. Stimulation of in-vitro antibody production and concanavalin-A induced mouse spleen cell mitogenesis by prolactin. Int J Immunopharmacol 1987; 14: 11–20
   PubMedGoogle Scholar
• Viselli S M, Stanek E M, Mukhergee P, Hymer W C, Mastro A M. Prolactin-induced mitogenesis of lymphocytes from ovariectomized rats. Endocrinol 1991; 129: 983–990
   PubMed Web of Science ®Google Scholar
• Walker S E, Allen S H, Hoffman R W, McMurray R W. Prolactin: a stimulator of disease activity in systemic lupus erythematosus. Lupus 1995; 4: 3–9
   PubMed Web of Science ®Google Scholar
• Papanicolaou D A, Petrides J S, Tsigos C, Bina S, Kalogeras K T, Wilder R, Gold P W, Deuster P A, Chrousos G P. Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines. Am J Physiol 1996; 271: E601–E605
   PubMed Web of Science ®Google Scholar
• Papanicolaou D A, Wilder R L, Manolagas S C, Chrousos G P. NIH Conference. The pathophysiologic role of Interleukin-6 in human disease. Ann Intern Med 1998; 128: 127–137
   PubMed Web of Science ®Google Scholar
• Zhou D, Kusnecov A W, Shurin M R, DePaoli M, Rabin S. Exposure to physical and psychological stressors elevates plasma interleukin-6: relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinol 1993; 133: 2523–2530
   PubMed Web of Science ®Google Scholar
• Heitkemper M, Jarrett M, Cain K, Shaver J, Bond E, Woods N F, Walker E. Increased urine catecholamine and cortisol in women with Irritable Bowel Syndrome. Am J Gastroenterol 1996; 91: 906–913
   PubMed Web of Science ®Google Scholar
• Gwee K A, Graham J C, McKendrick M W, Collins S M, Marshall J S, Read N W. Psychological scores and persistence of irritable bowel syndrome after infectious diarrhea. Lancet 1996; 347: 150–153
   PubMed Web of Science ®Google Scholar
• Crofford L J. Neuroendocrine aspects of fibromyalgia. J Musculoskel Pain 1994; 2(3)125–133
   Google Scholar
• Neal K R, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ 1997; 314: 779–782
   PubMed Web of Science ®Google Scholar
• Buskila D, Gladman D D, Langevitz P, Urowitz S, Smythe H A. Fibromyalgia in human immunodeficiency virus infection. J Rheumatol 1990; 17: 1202–1206
   PubMed Web of Science ®Google Scholar
• Simms R W, Zerbini C AF, Ferrante N, Anthony J, Felson D, Craven D E. Fibromyalgia syndrome in patients infected with human immunodeficiency virus. Am J Med 1992; 92: 368–374
   PubMed Web of Science ®Google Scholar
• Nash P, Chard M, Hazleman B. Chronic coxsackie B infection mimicking primary fibromyalgia. J Rheumatol 1989; 16: 1506–1508
   PubMed Web of Science ®Google Scholar
• Leventhal L J, Naides S J, Freundlich B. Fibromyalgia and parvovirus infection. Arthritis Rheum 1991; 34: 1319–1324
   PubMed Web of Science ®Google Scholar
• Rivera J, Diego A, Troichet I M, Monforte G A. Fibromyalgia-associated hepatitis C virus infection. Br J Rheumatol 1997; 36: 981–985
   PubMedGoogle Scholar
• Buskila D, Shnaider A, Neumann L, Zilberman D, Hilzenrat N, Sikuler E. Fibromyalgia in hepatitis C virus infection. Another infectious disease relationship. Arch Intern Med 1997; 157: 2497–2500
   PubMed Web of Science ®Google Scholar
• Gwee K A, Collins S M, Marshall J S, Underwood J E, Moochala S M, Read N W. Evidence of inflammatory pathogenesis in post-infectious irritable bowel syndrome. Gastroenterology 1998; 114: A758
   Web of Science ®Google Scholar
• O'Sullivan M, Breslin N P, Harman I, Clayton N, Bountra C, McLaren A, O'Morain C A. Increased mucosal mast cells in irritable bowel syndrome (IBS). Gastroenterology 1998; 114: A816
   Google Scholar
• Collins S M. Irritable bowel syndrome could be an inflammatory disorder. Eur J Gastroenterol Hepatol 1994; 6: 478–482
   Web of Science ®Google Scholar
• Collins S M. The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders. Gastroenterology 1996; 111: 1683–1699
   PubMed Web of Science ®Google Scholar
• Marzio L, Biennerhassett P, Chiverton S, Vermillion D L, Langer J, Collins S M. Altered smooth muscle function in worm-free gut regions of Trichenella-infected rats. Am J Physiol 1990; 259: G306–313
   Google Scholar
• Collins S M, McHugh K, Jacobson K, Khan I, Riddell R, Murase K, Weingarten H P. Previous inflammation alters the response of the rat colon to stress. Gastroenterology 1996; 111: 1509–1515
   PubMed Web of Science ®Google Scholar
• McKendrick M W, Read N W. Irritable bowel syndrome-post salmonella infection. J Infection 1994; 29: 1–3
   PubMed Web of Science ®Google Scholar
• Isgar B, Harman M, Kaye M D, Whorwell P J. Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut 1983; 24: 190–192
   PubMed Web of Science ®Google Scholar
• Yunus M B. Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanism with peripheral modulation. J Rheumatol 1992; 19: 846–850
   PubMed Web of Science ®Google Scholar
• Yunus M B. Psychological aspects of fibromyalgia syndrome: a component of the dysfunctional syndrome. Ballieres Clin Rheumatol 1994; 8: 811–837
   PubMed Web of Science ®Google Scholar